Annual CFO
-$4.11 M
+$532.60 K+11.46%
01 December 2023
Summary:
Xenetic Biosciences annual cash flow from operations is currently -$4.11 million, with the most recent change of +$532.60 thousand (+11.46%) on 01 December 2023. During the last 3 years, it has risen by +$153.00 thousand (+3.59%). XBIO annual CFO is now -375.34% below its all-time high of $1.49 million, reached on 31 December 2017.XBIO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$459.00 K
+$66.10 K+12.59%
01 September 2024
Summary:
Xenetic Biosciences quarterly cash flow from operations is currently -$459.00 thousand, with the most recent change of +$66.10 thousand (+12.59%) on 01 September 2024. Over the past year, it has increased by +$490.60 thousand (+51.66%). XBIO quarterly CFO is now -109.49% below its all-time high of $4.84 million, reached on 31 December 2017.XBIO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$2.94 M
+$490.60 K+14.32%
01 September 2024
Summary:
Xenetic Biosciences TTM cash flow from operations is currently -$2.94 million, with the most recent change of +$490.60 thousand (+14.32%) on 01 September 2024. Over the past year, it has increased by +$1.14 million (+27.89%). XBIO TTM CFO is now -296.52% below its all-time high of $1.49 million, reached on 31 December 2017.XBIO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XBIO Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.5% | +51.7% | +27.9% |
| 3 y3 years | +3.6% | +55.6% | +30.6% |
| 5 y5 years | +36.4% | +81.0% | +49.0% |
XBIO Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +13.2% | at high | +78.0% | at high | +45.2% |
| 5 y | 5 years | at high | +36.4% | at high | +81.0% | at high | +54.1% |
| alltime | all time | -375.3% | +67.6% | -109.5% | +90.1% | -296.5% | +76.8% |
Xenetic Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$459.00 K(-12.6%) | -$2.94 M(-14.3%) |
| June 2024 | - | -$525.10 K(-54.7%) | -$3.43 M(-17.8%) |
| Mar 2024 | - | -$1.16 M(+46.2%) | -$4.17 M(+1.4%) |
| Dec 2023 | -$4.11 M(-11.5%) | -$793.00 K(-16.5%) | -$4.11 M(+1.0%) |
| Sept 2023 | - | -$949.60 K(-25.2%) | -$4.07 M(-3.1%) |
| June 2023 | - | -$1.27 M(+15.1%) | -$4.20 M(+14.8%) |
| Mar 2023 | - | -$1.10 M(+46.8%) | -$3.66 M(-21.2%) |
| Dec 2022 | -$4.65 M(-1.9%) | -$750.90 K(-30.4%) | -$4.65 M(-13.2%) |
| Sept 2022 | - | -$1.08 M(+48.1%) | -$5.35 M(+0.9%) |
| June 2022 | - | -$728.90 K(-65.1%) | -$5.31 M(+0.0%) |
| Mar 2022 | - | -$2.09 M(+43.1%) | -$5.31 M(+12.0%) |
| Dec 2021 | -$4.74 M(+11.0%) | -$1.46 M(+41.2%) | -$4.74 M(+11.9%) |
| Sept 2021 | - | -$1.03 M(+42.2%) | -$4.23 M(+0.5%) |
| June 2021 | - | -$726.80 K(-52.2%) | -$4.21 M(-12.0%) |
| Mar 2021 | - | -$1.52 M(+59.3%) | -$4.79 M(+12.2%) |
| Dec 2020 | -$4.27 M(-33.3%) | -$953.70 K(-5.8%) | -$4.27 M(-14.5%) |
| Sept 2020 | - | -$1.01 M(-22.2%) | -$4.99 M(-22.0%) |
| June 2020 | - | -$1.30 M(+30.0%) | -$6.40 M(+4.1%) |
| Mar 2020 | - | -$1.00 M(-40.4%) | -$6.15 M(-4.0%) |
| Dec 2019 | -$6.40 M(-1.0%) | -$1.68 M(-30.6%) | -$6.40 M(+11.1%) |
| Sept 2019 | - | -$2.42 M(+129.9%) | -$5.76 M(+14.9%) |
| June 2019 | - | -$1.05 M(-16.2%) | -$5.01 M(-17.1%) |
| Mar 2019 | - | -$1.25 M(+20.5%) | -$6.05 M(-6.4%) |
| Dec 2018 | -$6.46 M(-532.6%) | -$1.04 M(-37.6%) | -$6.46 M(+1005.5%) |
| Sept 2018 | - | -$1.67 M(-20.1%) | -$584.70 K(+5.6%) |
| June 2018 | - | -$2.09 M(+25.3%) | -$553.80 K(+22.1%) |
| Mar 2018 | - | -$1.67 M(-134.5%) | -$453.40 K(-130.3%) |
| Dec 2017 | $1.49 M | $4.84 M(-395.5%) | $1.49 M(-118.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$1.64 M(-17.6%) | -$7.97 M(+8.3%) |
| June 2017 | - | -$1.99 M(-807.9%) | -$7.36 M(+9.3%) |
| Mar 2017 | - | $280.80 K(-106.1%) | -$6.73 M(-23.4%) |
| Dec 2016 | -$8.79 M(+65.8%) | -$4.62 M(+349.4%) | -$8.79 M(+66.5%) |
| Sept 2016 | - | -$1.03 M(-24.3%) | -$5.28 M(-14.9%) |
| June 2016 | - | -$1.36 M(-23.4%) | -$6.21 M(+23.1%) |
| Mar 2016 | - | -$1.77 M(+59.1%) | -$5.04 M(-4.9%) |
| Dec 2015 | -$5.30 M(-58.2%) | -$1.12 M(-43.0%) | -$5.30 M(-22.6%) |
| Sept 2015 | - | -$1.96 M(+910.0%) | -$6.85 M(-9.6%) |
| June 2015 | - | -$193.60 K(-90.5%) | -$7.58 M(-28.5%) |
| Mar 2015 | - | -$2.04 M(-23.6%) | -$10.60 M(-16.5%) |
| Dec 2014 | -$12.68 M(+109.6%) | -$2.66 M(-0.7%) | -$12.68 M(+24.4%) |
| Sept 2014 | - | -$2.68 M(-16.5%) | -$10.19 M(+40.4%) |
| June 2014 | - | -$3.21 M(-22.1%) | -$7.26 M(+80.1%) |
| Mar 2014 | - | -$4.12 M(+2282.4%) | -$4.03 M(-3848.4%) |
| Dec 2013 | -$6.05 M(-2256.8%) | - | - |
| Nov 2013 | - | -$173.10 K(-169.1%) | $107.50 K(-61.7%) |
| Aug 2013 | - | $250.40 K(+1355.8%) | $280.60 K(+864.3%) |
| Aug 2013 | $280.60 K(-104.5%) | - | - |
| May 2013 | - | $17.20 K(+32.3%) | $29.10 K(-2178.6%) |
| Feb 2013 | - | $13.00 K(>+9900.0%) | -$1400.00(-87.5%) |
| Dec 2012 | -$6.26 M(>+9900.0%) | - | - |
| Nov 2012 | - | $0.00(-100.0%) | -$11.20 K(-13.8%) |
| Aug 2012 | - | -$1100.00(-91.7%) | -$13.00 K(+9.2%) |
| Aug 2012 | -$13.00 K | - | - |
| May 2012 | - | -$13.30 K(-515.6%) | -$11.90 K(-950.0%) |
| Feb 2012 | - | $3200.00(-277.8%) | $1400.00(-177.8%) |
| Nov 2011 | - | -$1800.00 | -$1800.00 |
FAQ
- What is Xenetic Biosciences annual cash flow from operations?
- What is the all time high annual CFO for Xenetic Biosciences?
- What is Xenetic Biosciences annual CFO year-on-year change?
- What is Xenetic Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Xenetic Biosciences?
- What is Xenetic Biosciences quarterly CFO year-on-year change?
- What is Xenetic Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Xenetic Biosciences?
- What is Xenetic Biosciences TTM CFO year-on-year change?
What is Xenetic Biosciences annual cash flow from operations?
The current annual CFO of XBIO is -$4.11 M
What is the all time high annual CFO for Xenetic Biosciences?
Xenetic Biosciences all-time high annual cash flow from operations is $1.49 M
What is Xenetic Biosciences annual CFO year-on-year change?
Over the past year, XBIO annual cash flow from operations has changed by +$532.60 K (+11.46%)
What is Xenetic Biosciences quarterly cash flow from operations?
The current quarterly CFO of XBIO is -$459.00 K
What is the all time high quarterly CFO for Xenetic Biosciences?
Xenetic Biosciences all-time high quarterly cash flow from operations is $4.84 M
What is Xenetic Biosciences quarterly CFO year-on-year change?
Over the past year, XBIO quarterly cash flow from operations has changed by +$490.60 K (+51.66%)
What is Xenetic Biosciences TTM cash flow from operations?
The current TTM CFO of XBIO is -$2.94 M
What is the all time high TTM CFO for Xenetic Biosciences?
Xenetic Biosciences all-time high TTM cash flow from operations is $1.49 M
What is Xenetic Biosciences TTM CFO year-on-year change?
Over the past year, XBIO TTM cash flow from operations has changed by +$1.14 M (+27.89%)